期刊文献+

Krüppel-like factor 8 is a potential prognostic factor for pancreatic cancer 被引量:9

Krüppel-like factor 8 is a potential prognostic factor for pancreatic cancer
原文传递
导出
摘要 Background Pancreatic cancer is a lethal disease that is often diagnosed at an advanced stage.There is a lack of information to predict the prognosis of pancreatic cancer.Krüppel-like factor (KLF) 8 has been found to be deregulated in multiple cancers,and its high expression was correlated with poor prognosis.However,so far,no information was reported about the expression of KLF8 in pancreatic cancer.In the present study,we investigated,possibly for the first time,the expression of KLF8 in pancreatic cancer samples and analyzed its correlation with clinical parameters and overall survival (OS) rate.Methods We used immunohistochemical staining to detect KLF8 in 68 samples from patients who underwent surgery and its correlation with the clinicopathological characteristics.We used Kaplan-Meier curve to analyze the relationship between KLF8 expression and the OS time.Univariate analysis was performed in addition to multivariate hazard models with clinicopathological features to assess KLF8 as an independent prognostic factor.Results KLF8 was present in the cytoplasm of pancreatic cancer cells and 52.9% of the 68 cases had positive expression.KLF8 expression was not associated with sex,age,tumor location,lymph node stage,and metastasis stage,but was associated with tumor stage (P=0.04).Kaplan-Meier method demonstrated that patients with negative expression of KLF8 had a better prognosis.In univariate and multivariate models,KLF8 was a significant predictor of OS in pancreatic cancer.Conclusion Our results revealed that KLF8 may be a potential prognostic factor for pancreatic cancer. Background Pancreatic cancer is a lethal disease that is often diagnosed at an advanced stage.There is a lack of information to predict the prognosis of pancreatic cancer.Krüppel-like factor (KLF) 8 has been found to be deregulated in multiple cancers,and its high expression was correlated with poor prognosis.However,so far,no information was reported about the expression of KLF8 in pancreatic cancer.In the present study,we investigated,possibly for the first time,the expression of KLF8 in pancreatic cancer samples and analyzed its correlation with clinical parameters and overall survival (OS) rate.Methods We used immunohistochemical staining to detect KLF8 in 68 samples from patients who underwent surgery and its correlation with the clinicopathological characteristics.We used Kaplan-Meier curve to analyze the relationship between KLF8 expression and the OS time.Univariate analysis was performed in addition to multivariate hazard models with clinicopathological features to assess KLF8 as an independent prognostic factor.Results KLF8 was present in the cytoplasm of pancreatic cancer cells and 52.9% of the 68 cases had positive expression.KLF8 expression was not associated with sex,age,tumor location,lymph node stage,and metastasis stage,but was associated with tumor stage (P=0.04).Kaplan-Meier method demonstrated that patients with negative expression of KLF8 had a better prognosis.In univariate and multivariate models,KLF8 was a significant predictor of OS in pancreatic cancer.Conclusion Our results revealed that KLF8 may be a potential prognostic factor for pancreatic cancer.
出处 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第5期856-859,共4页 中华医学杂志(英文版)
基金 This study was supported by the National Natural Science Foundation of China,China Health Industry Research and Special Fund
关键词 Krüppel-like factor 8 prognostic factor pancreatic cancer SURVIVAL Krüppel-like factor 8 prognostic factor pancreatic cancer survival
  • 相关文献

参考文献1

二级参考文献17

  • 1Zhou J,Enewold L,Stojadinovic A,Clifton GT,Potter JF,Peoples GE,et al.Incidence rates of exocrine and endocrine pancreatic cancers in the United States.Cancer Causes Control 2010; 21:853-861.
  • 2Amptoulach S,Kalaitzakis E,Azam F.Adjuvant chemotherapy should be used as the standard of care for resectable pancreatic cancer.Cancer Ther 2009; 7:227-233.
  • 3Wong A,Soo RA,Yong WP,Innocenti F.Clinical pharmacology and pharmacogenetics of gemcitabine.Drug Metab Rev 2009; 41:77-88.
  • 4Shi JY,Shi ZZ,Zhang SJ,Zhu YM,Gu BW,Li G,et al.Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients.Pharmacogenetics 2004; 14:759-768.
  • 5Joerger M,Bosch TM,Doodeman VD,Beijnen JH,Smits PH,Schellens JH.Novel deoxycytidine kinase gene polymorphisms:a population screening study in Caucasian healthy volunteers.Eur J Clin Pharmacol 2006; 62:681-684.
  • 6Okazaki T,Javle M,Tanaka M,Abbruzzese JL,Li D.Single nucleotide polymorphisms of gemcitabine metabolic genes and pancreatic cancer survival and drug toxicity.Clin Cancer Res 2010; 16:320-329.
  • 7Lamba JK,Crews K,Pounds S,Schuetz EG,Gresham J,Gandhi V,et al.Pharmacogenetics of deoxycytidine kinase:identification and characterization of novel genetic variants.J Pharmacol Exp Ther 2007; 323:935-945.
  • 8Kim SR,Saito Y,Maekawa K,Sugiyama E,Kaniwa N,Ueno H,et al.Twenty novel genetic variations and haplotype structures of the DCK gene encoding human deoxycytidine kinase (dCK).Drug Metab Pharmacokinet 2008; 23:379-384.
  • 9Jimeno A,Hidalgo M.Molecular biomarkers:their increasing role in the diagnosis,characterization,and therapy guidance in pancreatic cancer.Mol Cancer Ther 2006; 5:787-796.
  • 10Mini E,Nobili S,Caciagli B,Landini I,Mazzei T.Cellular pharmacology of gemcitabine.Ann Oncol 2006; 17 (Suppl 5):7-12.

共引文献4

同被引文献28

引证文献9

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部